Zehra Aycan, Elvan Bayramoglu, Veysel Nijat Bas

Proximal hypospadias and 46XY disorder of sex development; which patient with hypospadias needs to be investigated?

Aim: This study examines the distribution of genital abnormalities based on physical examination of our patients with 46, XY disorders of sex development (46, XY DSD), and aims to define severity and frequency of hypospadias in 46, XY DSD. Hypospadias is a relatively prevalent congenital anomaly. Although genetic, environmental and hormonal factors are considered to be responsible, etiology is not clarified in several hypospadias cases. Materials and Methods: Clinical, laboratory and genetic records of all cases with 46, XY DSD, who were evaluated by the sex determination monitoring board were retrospectively reviewed. In the diagnosis, hypospadias cases were examined in terms of the place of hypospadias and coexisting other external genital findings. Results: There were 72 patients with 46, XY DSD. 5-α reductase deficiency [n=32 (44.4%)] was the most commonly encountered diagnosis followed by androgen insensitivity syndrome [n=26, (36.1%)]. Proximal hypospadias were presented in 44.4% (n: 32) of the cases and only 6 of them (18.8%) were isolated hypospadias. In 81.2% of these cases, at least one of the anomalies such as cordi, bifid scrotum, undescended testis and micropenis accompanied proximal hypospadias. None of the distal hypospadias cases were referral clinic finding. Conclusions: 46 XY DSD is a heterogeneous group of patients with a varying age of presentation and a diverse clinical profile. It can be stated that proximal hypospadias is the most common referral clinic finding of 46, XY DSD, and the risk of 46, XY DSD increases with the intensifying degree of hypospadias and the presence of coexisting genital abnormalities such as cordi, bifid scrotum, undescended testis and micropenis.

PDF

___

1. Vasundhera C, Jyotsna VP, Kandasamy D, et al. Clinical, hormonal and radiological profile of 46XY disorders of sexual development. Indian J Endocrinol Metab 2016;20:300-7.
2. Savas Erdeve S, Aycan Z, Berberoglu M, et al. A novel mutation of 5alpha-steroid reductase 2 deficiency (CD 65 ALA-PRO) with severe virilization defect in a Turkish family and difficulty in gender assignment. Eur J Pediatr 2010;169:991-5.
3. Porter MP, Faizan MK, Grady RW, et al. Hypospadias in Washington State: maternal risk factors and prevalence trends. Pediatrics 2005;115:495-9.
4. Cox MJ, Coplen DE, Austin PF. The incidence of disorders of sexual differentiation and chromosomal abnormalities of cryptorchidism and hypospadias stratified by meatal location. J Urol 2008;180:2649- 52.
5. Boehmer AL, Nijman RJ, Lammers BA, et al. Etiological studies of severe or familial hypospadias. J Urol 2001;165:1246-54.
6. Albers N, Ulrichs C, Glüer S, et al. Etiologic classification of severe hypospadias: implications for prognosis and management. J Pediatr 1997;131:386-92.
7. Lee PA, Houk CP, Ahmed SF, et al. International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 2006;118:488-500.
8. Sinnecker GH, Hiort O, Dibbelt L, et al. Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency. Am J Med Genet 1996;63:223-30.
9. Ahmed SF, Keir L, McNeilly J, et al. The concordance between serum anti-Mullerian hormone and testosterone concentrations depends on duration of hCG stimulation in boys undergoing investigation of gonadal function. Clin Endocrinol 2010;72:814-9.
10. Lovell-Badge R. The role of Sry in mammalian sex determination. Ciba Found Symp 1992;165:162-82.
11. Rey R, Lukas‑Croisier C, Lasala C, et al. AMH/MIS: What we know already about the gene, the protein and its regulation. Mol Cell Endocrinol 2003;211:21‑31.
12. Al-Jurayyan NA, Al Issa SD, Al Nemri AM, et al. The spectrum of 46,XY disorders of sex development in a University centre in Saudi Arabia. J Pediatr Endocrinol Metab 2015;28:1123-7.
13. Abdullah MA, Saeed V, Abass A, et al. Disorders of sex development among Sudanese children; 5-year experience of pediatric endocrinology clinic. J Pediatr Endocrinol Metab 2012;25:1065-72.
14. Joshi RR, Rao S, Desai M. Etiology and clinical profile of ambiguous genitalia an overview of 10 years experience. Indian Pediatr 2006;43:974-9.
15. Chauhan V, Dada R, Jain V. Aetiology and clinical profile of children with 46, XY differences of sex development at an Indian referral centre. Andrologia 2016;49:12663.
16. Spencer JR, Torrado T, Sanchez RS, Vaughanet al. Effects of flutamide and finasteride on rat testicular descent. Endocrinology 1991;129:741-8.
17. Husmann DA, McPhaul MJ. Time-specific androgen blockade with flutamide inhibits testicular descent in the rat. Endocrinology 1991;129:1409-16.
18. Rohatgi M, Menon PS, Verma IC, et al. The presence of intersexuality in patients with advanced hypospadias and undescended gonads. J Urol 1987;137:263-7.
19. Palmer BW, Reiner W, Kropp BP. Proximal hypospadias repair outcomes inpatients with a specific disorder of sexual development diagnosis. Adv Urol 2012;2012:708301.
20. Sekaran P, O'Toole S, Flett M, et al. Increased occurrence of disorders of sex development, prematurity and intrauterine growth restriction in children with proximal hypospadias associated with undescended testes. J Urol 2013;189:1892-6.